Reporters, editors, reviewers.
Every CannIntel byline links to the reporter who wrote it. Every medical story is reviewed by a licensed clinician before publication. Here's who we are.
Marcus has covered cannabis policy and markets for nine years, previously reporting from Washington for a national trade publication. He oversees CannIntel's editorial standards and original reporting.
Lena reviews every medical and research article on CannIntel. She is a licensed pharmacist with a research focus on cannabinoid pharmacokinetics and drug interactions.
Rio has run commercial cannabis cultivation operations across three states and now reports on growing science, genetics, and emerging plant pathologies — including hop latent viroid.
Harper covers new breeder releases, cup winners, and the genetics moving the legacy market. Her strain reviews involve verified terpene panels and side-by-side grow logs.
Tomas tracks every state legalization bill, ballot measure, and licensing round. He maintains the CannIntel legalization tracker.
Kira covers the publicly-traded cannabis sector, MSO earnings, M&A activity, and wholesale pricing trends. Previously a junior equity analyst on a cannabis-focused fund.